Abstract: Compounds of formula (I):
and pharmaceutically acceptable salts thereof, wherein one of R1 and R2 is H and the other is N═C(NH2)2 or NHC(═NH)NH2, and the other substituents are as defined herein, are urokinase (uPA) inhibitors.
Type:
Grant
Filed:
May 30, 2000
Date of Patent:
June 19, 2001
Assignee:
Pfizer Inc.
Inventors:
Roger Peter Dickinson, Christopher Gordon Barber, Paul Vincent Fish